Oligonukleotīdu sintēze
Oligonukleotīdu sintēze is a public tender published 29 Nov 2023 by APP Latvijas Biomedicīnas pētījumu un studiju centrs, bids due 14 Dec 2023, estimated €41,000, status cancelled (EIS (Latvian Electronic Procurement System), as of 29 Sep 2026).
Source: EIS (Latvian Electronic Procurement System), retrieved 29 September 2026.
- Contracting authority
- APP Latvijas Biomedicīnas pētījumu un studiju centrs
- Country
- Latvia tenders (LV)
- Status
- cancelled
- Source
- EIS
- Published
- 2023-11-29
- Deadline
- 2023-12-14
- Estimated value
- €41,000
- CPV
- 24950000-8 — Specialised chemical products
- Category hubs
- Chemical products
- Original notice
- View at source
Nr: BMC 2023/526 Procedūra: Mazie iepirkumi Profils: PIL_9_panta_kārtībā_(līdz 30.06.2024.) Priekšmets: Piegāde Vieta: Riga, Rātsupītes 1 k-1 (LATVIJA), LV-1067 Termiņš: 24 Vērtība: no 1000.00 līdz 41000.00 EUR Metode: Tikai zemākās cenas vai tikai izmaksu vērtēšana Kontakts:…
Frequently asked questions
- What is the deadline for this tender?
- Bids are due 14 December 2023.
- What is the status of this tender?
- The tender status is cancelled.
Full tender details (members only)
The following on this tender is available to signed-in TendeRadar users:
- Full tender description & requirements
- Tender documents & specifications
- Why-it-fits matching for your company & market analytics